Quantrx Biomedical Corp (QTXB) financial statements (2021 and earlier)

Company profile

Business Address P.O. BOX 4960
TUALATIN, OR 97062
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 000000
Cash and cash equivalents 000000
Receivables      0
Prepaid expense 000000
Deposits current assets     0 
Other undisclosed current assets   0   
Total current assets: 001000
Noncurrent Assets
Property, plant and equipment     00
Long-term investments and receivables  01000
Long-term investments  01000
Intangible assets, net (including goodwill)   (0)000
Intangible assets, net (excluding goodwill)   (0)000
Other undisclosed noncurrent assets   0   
Total noncurrent assets:  01000
TOTAL ASSETS: 011000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 100001
Accounts payable 000000
Accrued liabilities  00000
Interest and dividends payable 1     
Debt 12211 
Due to related parties 00  0 
Other undisclosed current liabilities 000101
Total current liabilities: 222222
Noncurrent Liabilities
Long-term debt and lease obligation    000
Long-term debt, excluding current maturities    000
Total noncurrent liabilities:    000
Total liabilities: 222222
Stockholders' equity
Stockholders' equity attributable to parent, including: (2)(2)(1)(2)(1)(1)
Preferred stock 000000
Common stock 111111
Common stock, value, subscriptions 000   
Additional paid in capital 494949494948
Accumulated deficit (52)(51)(51)(51)(51)(51)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity: (2)(2)(1)(2)(1)(1)
TOTAL LIABILITIES AND EQUITY: 011000

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues  0  00
Revenue, net  00
Net investment income  0    
Cost of revenue (0)(0)(2)(0)(0) 
Cost of goods and services sold (0)     
Gross profit: (0)(0)(2)(0)(0)0
Operating expenses (0)(0)1(0)(0)(1)
Other undisclosed operating income (loss)  (0)   1
Operating loss: (0)(0)(0)(0)(0)(0)
Nonoperating income (expense) (0)(1)1(0) 0
Investment income, nonoperating      0
Other nonoperating income (expense) (0)(1)1(0)  
Interest and debt expense (0)0(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes: (1)(1)1(0)(0)(0)
Income from equity method investments      0
Other undisclosed income (loss) from continuing operations before income taxes 0(0)00(0)(0)
Net income (loss) available to common stockholders, diluted: (1)(1)1(0)(0)(1)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (1)(1)1(0)(0)(1)
Comprehensive income (loss), net of tax, attributable to parent: (1)(1)1(0)(0)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: